103 related articles for article (PubMed ID: 3059923)
1. The biochemistry and pharmacology of mesoamygdaloid dopamine neurons.
Kilts CD; Anderson CM; Ely TD; Mailman RB
Ann N Y Acad Sci; 1988; 537():173-87. PubMed ID: 3059923
[TBL] [Abstract][Full Text] [Related]
2. Absence of synthesis-modulating nerve terminal autoreceptors on mesoamygdaloid and other mesolimbic dopamine neuronal populations.
Kilts CD; Anderson CM; Ely TD; Nishita JK
J Neurosci; 1987 Dec; 7(12):3961-75. PubMed ID: 3121804
[TBL] [Abstract][Full Text] [Related]
3. Mesoamygdaloid dopamine neurons: differential rates of dopamine turnover in discrete amygdaloid nuclei of the rat brain.
Kilts CD; Anderson CM
Brain Res; 1987 Jul; 416(2):402-8. PubMed ID: 3620969
[TBL] [Abstract][Full Text] [Related]
4. Selective activation of mesoamygdaloid dopamine neurons by conditioned stress: attenuation by diazepam.
Coco ML; Kuhn CM; Ely TD; Kilts CD
Brain Res; 1992 Sep; 590(1-2):39-47. PubMed ID: 1422845
[TBL] [Abstract][Full Text] [Related]
5. Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain.
Scibilia RJ; Lachowicz JE; Kilts CD
Synapse; 1992 Jun; 11(2):146-54. PubMed ID: 1385664
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of the mesotelencephalic dopamine fibers: physiology and pharmacology.
Gardner EL; Ashby CR
Neurosci Biobehav Rev; 2000 Jan; 24(1):115-8. PubMed ID: 10654666
[TBL] [Abstract][Full Text] [Related]
7. Dopamine receptor subtypes selectively modulate excitatory afferents from the hippocampus and amygdala to rat nucleus accumbens neurons.
Charara A; Grace AA
Neuropsychopharmacology; 2003 Aug; 28(8):1412-21. PubMed ID: 12799620
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of mesocortical dopamine neurons.
Bannon MJ; Roth RH
Pharmacol Rev; 1983 Mar; 35(1):53-68. PubMed ID: 6138783
[TBL] [Abstract][Full Text] [Related]
9. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor-mediated regulation of incertohypothalamic dopaminergic neurons in the male rat.
Lookingland KJ; Moore KE
Brain Res; 1984 Jun; 304(2):329-38. PubMed ID: 6331589
[TBL] [Abstract][Full Text] [Related]
11. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
Galloway MP; Wolf ME; Roth RH
J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
[TBL] [Abstract][Full Text] [Related]
12. Brain stimulation reward and dopamine terminal fields. I. Caudate-putamen, nucleus accumbens and amygdala.
Prado-Alcalá R; Wise RA
Brain Res; 1984 Apr; 297(2):265-73. PubMed ID: 6722544
[TBL] [Abstract][Full Text] [Related]
13. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
Nowak JZ; Arbilla S; Galzin AM; Langer SZ
J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
[TBL] [Abstract][Full Text] [Related]
14. Transmitter release from transplants of fetal ventral mesencephalon or locus coeruleus in the rat frontal cortex and nucleus accumbens: effects of pharmacological and behaviorally activating stimuli.
Cenci MA; Kalén P; Duan WM; Björklund A
Brain Res; 1994 Apr; 641(2):225-48. PubMed ID: 8012825
[TBL] [Abstract][Full Text] [Related]
15. Response of ventral pallidal neurons to amygdala stimulation and its modulation by dopamine projections to nucleus accumbens.
Yim CY; Mogenson GJ
J Neurophysiol; 1983 Jul; 50(1):148-61. PubMed ID: 6875644
[TBL] [Abstract][Full Text] [Related]
16. Strain differences in mesotelencephalic dopaminergic neuronal regulation between Fischer 344 and Lewis rats.
Lindley SE; Bengoechea TG; Wong DL; Schatzberg AF
Brain Res; 1999 Jun; 832(1-2):152-8. PubMed ID: 10375661
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptors and ergot drugs. Evidence that an ergolene derivative is a differential agonist at subcortical limbic dopamine receptors.
Fuxe K; Fredholm BB; Agnati LF; Corrodi H
Brain Res; 1978 May; 146(2):295-311. PubMed ID: 647392
[TBL] [Abstract][Full Text] [Related]
18. Postnatal inorganic lead exposure reduces midbrain dopaminergic impulse flow and decreases dopamine D1 receptor sensitivity in nucleus accumbens neurons.
Tavakoli-Nezhad M; Pitts DK
J Pharmacol Exp Ther; 2005 Mar; 312(3):1280-8. PubMed ID: 15550573
[TBL] [Abstract][Full Text] [Related]
19. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
Jeziorski M; White FJ
Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
[TBL] [Abstract][Full Text] [Related]
20. Effects of BMY 14802, a potential antipsychotic drug, on rat brain dopaminergic function.
Matthews RT; McMillen BA; Sallis R; Blair D
J Pharmacol Exp Ther; 1986 Oct; 239(1):124-31. PubMed ID: 2876091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
